RT @AvestriaVC
Now that #JPM2023's over, we're looking ahead to one of the next conferences on our radar: @AmericanTelemed's #ATA2023 from 3/4 - 3/6 in San Antonio, TX. It'll focus on #telehealth and #virtualcare + host the Innovators Challenge final round!
Get tickets: https://gotelehealth.org/ata-2023/register/?pr=T1J0323

And yes, Illumina still produces microarray kits, even though these don't make it into the slide decks and presentations of the company in #JPM2023. In the methylation segment, Illumina started many years ago with a 27k array for human samples, which grew to the 450k array later.

RT @ADaviesDHCG@twitter.com

@rtnarch@twitter.com at the @endpts@twitter.com #JPM2023 event: ‘we should increase the pay of every FDA employee by 10% and they should spend one day a month in a pediatric cancer ward (aka the real world) …to understand the consequences of inaction’

🐦🔗: https://twitter.com/ADaviesDHCG/status/1612849192971689984

Another entity that made a big splash at #JPM2023 was InstaDeep, which in collaboration with Nvidia and TUM is creating s genomic language model to understand DNA function.

In #JPM2023 news, $RXRX Recursion Bio presented on January 10th, 2023 and the slides were made available for everyone to peruse. Initial slide portrays the Moore's Law vs Eroom's Law, and the opportunity for Compute-based Drug Discovery.

RT @AlbertVilella@twitter.com

In #JPM2023 and #NextGenerationSequencing news, Element Bio @ElemBio@twitter.com today steals the show by announcing the $200 Genome, available immediately for customers buying 3 AVITI benchtop sequencers. This is at least 6 months earlier than $ILMN Illumina's NovaSeq X Plus 25B flowcells. https://twitter.com/ElemBio/status/1613194406848258048

🐦🔗: https://twitter.com/AlbertVilella/status/1613214579202396162

RT @AlbertVilella@twitter.com

In #JPM2023 news, $AKYA Akoya Biosciences presented with their #SpatialBiology solutions. Here the 3 instruments lined up from Discovery to Translational to Clinical segments.

🐦🔗: https://twitter.com/AlbertVilella/status/1613467569263869954

RT @AlbertVilella@twitter.com

In #JPM2023 news, $DNA Ginkgo Bioworks also presented in January 11, 2023. Jason Kelly, one of the co-founders and CEO was the one leading the presentation.

🐦🔗: https://twitter.com/AlbertVilella/status/1613475369851518978

RT @AlbertVilella@twitter.com

In #JPM2023 news, $PACB PacBio presented on January 11, 2023. Christian Henry, President and CEO announcing that Revio already has 76 orders in the books.

🐦🔗: https://twitter.com/AlbertVilella/status/1613480600349937666

RT @AlbertVilella@twitter.com

In #JPM2023 news, $QSI Quantum-SI also presented on January 12, 2023. The company launched their Platinum protein sequencer a few weeks ago.

🐦🔗: https://twitter.com/AlbertVilella/status/1613847195580616705

RT @DivaBiotech@twitter.com

After a week in San Francisco for #JPM2023 i have come to the conclusion that its the scariest, dirtiest city I have experienced. I have lived in London, Cairo and Shanghai and SF is where I have felt the most unsafe. Such a shame for a city that generates so much $$$

🐦🔗: https://twitter.com/DivaBiotech/status/1613715978797592581

In #JPM2023, $NAUT Nautilus Bio didn't make their slides available, but they have a slide deck from an investor meeting in December 2022. They intend to launch their Proteome Analysis Platform in Mid-2024.

In #JPM2023 news, $SEER also presented. They are another of the Next Generation Proteomics Sequencing players. One of their USPs is that they have an approach capable of finding different protein variants that would be undistinguishable with affinity-based approaches.

In #JPM2023 news, $ABCL AbCellera also presented. They are an #Antibody Discovery engine with a large number of open projects with many large pharma companies. They have three type of programs.

In #JPM2023 news, $AZTA Azenta also presented. They acquired Genewiz a few years ago, and they continue looking at M&A to consolidate their positioning, especially in Services for Life Sciences.

In #JPM2023 news, $OLK Olink presented and showed good numbers, especially for their high-plex segment.

In #JPM2023 news, $QSI Quantum-SI also presented on January 12, 2023. The company launched their Platinum protein sequencer a few weeks ago.

In #JPM2023 news, $ABSI Absci presented on Thursday 12, 2023. Also following the trend of asking AI what they should do, the company's Chief Morale Officer was put to the task of discovering biologics on a computer. Well, DALL-E's interpretation of that was on a slide.

In #JPM2023 news, $OMIC Singular Genomics presented on January 12, 2023. They see a 2022 TAM for NGS of $6B, growing to $20B in 2030.

Did storms steal JPM's thunder? —Oramed's oral insulin flunks phase 3 diabetes test, sending stock down 70% — FDA no longer needs to require animal tests before human drug trials -- See more on our front page news http://bit.ly/w28kSd #california #sanfrancisco #jpm2023 #jpm23 #oralinsulin #diabetes #type2diabetes #clinicaltrials #fda #animalresearch #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma